APPLICATION
ANDA210985
TYPE
ANDA
ORIGINAL APPROVAL
2019-01-09
LATEST ACTION
2026-06-11
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
METHYLPREDNISOLONEDiscontinued
METHYLPREDNISOLONE 4MG · TABLET · ORAL
Approval history
2026-06-11Labeling · Supplement 5 · standardAP
2024-12-20Labeling · Supplement 4 · standardAP
2024-12-20Labeling · Supplement 3 · standardAP
2019-01-09UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.